Neuropsychobiology

 

Functional Interhemispheric Differences in Relation to Various Psychopathological Components of the Depressive Syndromes

A Pilot International Study
Monakhov K. · Perris C. · Botskarev V.K. · von Knorring L. · Nikiforov A.I.

Author affiliations

Department of Psychiatry, Umeå University, Umeå, and Department of Neurophysiology, Psychiatric Institute, Academy of Medical Sciences, Moscow

Related Articles for ""

Neuropsychobiology 1979;5:143–155

Log in to MyKarger to check if you already have access to this content.


Buy

  • FullText & PDF
  • Unlimited re-access via MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

CHF 38.00 *
EUR 35.00 *
USD 39.00 *

Select

KAB

Buy a Karger Article Bundle (KAB) and profit from a discount!


If you would like to redeem your KAB credit, please log in.


Save over 20% compared to the individual article price.

Learn more

Rent/Cloud

  • Rent for 48h to view
  • Buy Cloud Access for unlimited viewing via different devices
  • Synchronizing in the ReadCube Cloud
  • Printing and saving restrictions apply

Rental: USD 8.50
Cloud: USD 20.00

Select

Subscribe

  • Access to all articles of the subscribed year(s) guaranteed for 5 years
  • Unlimited re-access via Subscriber Login or MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

Subcription rates


Select
* The final prices may differ from the prices shown due to specifics of VAT rules.

Article / Publication Details

First-Page Preview
Abstract of Paper

Published online: February 15, 2008
Issue release date: 1979

Number of Print Pages: 13
Number of Figures: 0
Number of Tables: 0

ISSN: 0302-282X (Print)
eISSN: 1423-0224 (Online)

For additional information: https://www.karger.com/NPS

Abstract

Previous investigations from our laboratory have suggested a possible interhemispheric difference in brain functioning in relation to the severity of a depressive psychopathological process. The present study has been carried out to extend the previous fìndings to comprise a more detailed symptom analysis of the depressive syndrome, several EEG characteristics, and a new method of EEG analysis. 22 depressed patients, most of them previously untreated, participated in the study. The patients were rated by means of a highly reliable rating scale for depression, and an EEG record was obtained from each of them. Analysis of possible relationships among clinical symptoms and EEG characteristics from different parts of the brain showed a complex pattern, quite different for each symptom. First when a systemic structural analysis of the EEG was performed by means of a special computer program, differential EEG syndromes could be identifìed. Patients with a high level of anxiety-depression showed a more pronounced functional involvement of the left precentral region than less severely ill patients.

© 1979 S. Karger AG, Basel




Related Articles:


Article / Publication Details

First-Page Preview
Abstract of Paper

Published online: February 15, 2008
Issue release date: 1979

Number of Print Pages: 13
Number of Figures: 0
Number of Tables: 0

ISSN: 0302-282X (Print)
eISSN: 1423-0224 (Online)

For additional information: https://www.karger.com/NPS


Copyright / Drug Dosage / Disclaimer

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
TOP